Logo image of FLKS

Flexpharma Inc. (FLKS) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:FLKS -

0.6068
+0 (+0.23%)
Last: 7/19/2019, 8:00:00 PM
0.55
-0.06 (-9.36%)
After Hours: 7/19/2019, 8:00:00 PM

FLKS Key Statistics, Chart & Performance

Key Statistics
Market Cap10.96M
Revenue(TTM)683.80K
Net Income(TTM)-8.26M
Shares18.07M
Float15.41M
52 Week High1.49
52 Week Low0.26
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.88
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


FLKS short term performance overview.The bars show the price performance of FLKS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 60 80

FLKS long term performance overview.The bars show the price performance of FLKS in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of FLKS is 0.6068 null. In the past month the price increased by 25.11%. In the past year, price decreased by -30.65%.

Flexpharma Inc. / FLKS Daily stock chart

FLKS Latest News, Press Relases and Analysis

About FLKS

Company Profile

Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.

Company Info

Flexpharma Inc.

31 St. James Avenue 6thFloor

Boston MA 02116

CEO: William McVicar

Phone: 617-874-1821

Flexpharma Inc. / FLKS FAQ

Can you describe the business of Flexpharma Inc.?

Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.


Can you provide the latest stock price for Flexpharma Inc.?

The current stock price of FLKS is 0.6068 null. The price increased by 0.23% in the last trading session.


What is the dividend status of Flexpharma Inc.?

FLKS does not pay a dividend.


What is the ChartMill rating of Flexpharma Inc. stock?

FLKS has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


FLKS Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to FLKS. When comparing the yearly performance of all stocks, FLKS is a bad performer in the overall market: 69.29% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

FLKS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to FLKS. While FLKS seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

FLKS Financial Highlights

Over the last trailing twelve months FLKS reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS increased by 55.33% compared to the year before.


Industry RankSector Rank
PM (TTM) -1208.29%
ROA -115.76%
ROE -135.42%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%73.91%
Sales Q2Q%-32.91%
EPS 1Y (TTM)55.33%
Revenue 1Y (TTM)-38.97%

FLKS Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y54.92%
Revenue Next YearN/A

FLKS Ownership

Ownership
Inst Owners14.42%
Ins Owners19.7%
Short Float %N/A
Short RatioN/A